Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Swallowed Fluticasone in Eosinophilic Esophagitis
NCT00275561Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Nov 2005
- Primary completion
- Apr 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fluticasone in eosinophilic esophagitis (EoE), sponsored by Mayo Clinic. Primary endpoint: Number of Participants With Complete Response to Dysphagia at 6 weeks. Started Nov 2005; status: completed.
02
Drugs
fluticasone
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT00275561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00275561.